| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.01 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |